INS and Hypoglycemia: Although no randomized controlled trial has compared IGlar with NPH insulin in Thailand, the risk reduction of severe hypoglycemia by IGlar compared with NPH insulin was based on the results of a meta-analysis of randomized controlled trials, which is classified as the highest level of evidence.